Plain-English translation of NCT03827876 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Psoriasis research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing whether Enstilar® foam, a combination topical medication, works well when added to injectable psoriasis drugs you may already be taking (such as Enbrel or Humira). Researchers want to see if the medication helps improve psoriasis plaques over 16 weeks when used alongside your current treatment.
Some people with psoriasis continue to have visible skin patches even while taking injectable biologic medications. This trial explores whether adding this topical treatment could help control remaining plaques and improve results for patients whose current therapy alone isn't completely clearing their skin.
You likely qualify if…
You likely don't qualify if…
You would apply the topical foam once daily for the first 4 weeks, then every other day for 12 weeks—a total of 16 weeks. You'll continue taking your regular injectable medication throughout the trial. The study involves 30 participants total, and you would attend visits so researchers can track how your skin responds to the added treatment.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States
Phase
Post-approval monitoring
Sponsor
Psoriasis Treatment Center of Central New Jersey
Collaborators
LEO Pharma
Enrollment target
~30 participants
Started
January 2019
Primary completion
September 2019
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2019.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jerry Bagel, MD
Psoriasis Treatment Center of Central New Jersey
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.